Dr. Harkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2211 Lomas Blvd NE
# 1
Albuquerque, NM 87106Phone+1 505-272-4751Fax+1 505-272-8700
Education & Training
- University of New Mexico School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
- University of MarylandResidency, Internal Medicine, 1993 - 1995
- Sidney Kimmel Medical College at Thomas Jefferson University/Christiana Care Health ServicesInternship, Internal Medicine, 1992 - 1993
- University of Texas Southwestern Medical SchoolClass of 1992
Certifications & Licensure
- NM State Medical License 1995 - 2026
- TX State Medical License 1993 - 2012
- MD State Medical License 1995 - 1996
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 Start of enrollment: 2020 Apr 28
Roles: Contact, Principal Investigator
- Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 100 citationsThe Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.Narges Moghimi, Mario Di Napoli, José Biller, James E. Siegler, Rahul Shekhar
Current Neurology and Neuroscience Reports. 2021-06-28 - 61 citationsBaricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01 - 97 citationsEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18
Press Mentions
- From Research to Clinical Practice: Applying Lessons Learned from Long COVID StudyJuly 11th, 2024
- UNM to Take Part in National Studies on 'Long COVID'October 26th, 2021
- Informatics Expert Presses Congress for Long COVID 'Moonshot'January 23rd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: